“Further, we expect that vaccine manufacturers will remain ready to support potential surges in demand and evolving circumstances of COVID-19,” Becerra wrote. He added that HHS expects manufacturers planning to offer the vaccines this fall, which will be updated from the currently available bivalent boosters, are preparing an ample supply of doses for the 2023-24 Covid-19 vaccination campaign. Those three companies, which manufacture the only Covid-19 vaccines currently available in the US, are advised that they should plan for this fall’s vaccine supply and regulatory submissions in enough time for the US Food and Drug Administration to take action and the US Centers for Disease Control and Prevention to make recommendations on the vaccinations “by the latter part of September,” Becerra wrote in a draft of the letter obtained by CNN. On Thursday morning, US Department of Health and Human Services Secretary Xavier Becerra sent a letter to the CEOs of Pfizer, Moderna and Novavax detailing how, after the transition to commercialization, HHS expects “that vaccines will remain available in the types of locations where the public currently receives them – including pharmacies, clinics, healthcare provider offices, health departments, and other points of care – to maximize access.” Joe Raedle/Getty ImagesįDA recommends vaccine manufacturers make single-strain Covid-19 boosters that target Omicron spinoff XBB.1.5 for the fall Jackson Memorial Hospital began the vaccination of frontline healthcare workers joining with hospital systems around the country as the COVID-19 vaccine is rolled out. MIAMI, FLORIDA - DECEMBER 15: A healthcare worker at the Jackson Health Systems receives a Pfizer-BioNtech Covid-19 vaccine from Susana Flores Villamil, RN from Jackson Health Systems, at the Jackson Memorial Hospital on Decemin Miami, Florida.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |